标题：Research Grade Aflibercept 对照抗体,AntibodySystem Laboratories
链接：https://www.antibodysystem.com/product/658.html
名称：Research Grade Aflibercept 对照抗体,AntibodySystem Laboratories
CAS: 862111-32-8
货号：DHD12629
适用物种：Human
寄主物种：Homo sapiens
形式：Liquid
纯度：>95%
克隆性：Monoclonal
同种型：IgG1-Fc
应用：Research Grade Biosimilar
UniProt：P15692
靶点：Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A
用途范围：仅用于科研
储存：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
免费热线：027-65279366 /18108604356
QQ：2663991332
咨询邮箱：products@biolabreagent.com
选购商城：https://www.antibodysystem.com
微信公众平台：佰乐博生物Biolab Reagents
参考文献：
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. PMID: 23084240
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial. PMID: 35881122
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema: recent clinically relevant findings from DRCR.net Protocol T. PMID: 28837425
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial. PMID: 34351414
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. PMID: 26935357
Intravitreal Ziv-Aflibercept: A Comprehensive Review. PMID: 31314638
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB. PMID: 28106709
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial. PMID: 37535382
INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized Trial. PMID: 35234673
Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. PMID: 22949147
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial. PMID: 31037289
Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial. PMID: 29392288
Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications. PMID: 27166390
Aflibercept. PMID: 23444216
Aflibercept: A Review in Macular Oedema Secondary to Branch Retinal Vein Occlusion. PMID: 28365905
Aflibercept: A review of its effect on the treatment of exudative age-related macular degeneration. PMID: 30813810
Aflibercept: A Review in Metastatic Colorectal Cancer. PMID: 26220913
Up-to-date role of aflibercept in the treatment of colorectal cancer. PMID: 34085884
Intravitreal Ziv-Aflibercept: Clinical Effects and Economic Impact. PMID: 28971631
Aflibercept in age-related macular degeneration: evaluating its role as a primary therapeutic option. PMID: 28548650
Aflibercept in the Treatment of Diabetic Macular Edema: A Review and Consensus Paper. PMID: 29077188
Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal Vasculopathy. PMID: 37504966
Aflibercept: an update on recent milestones achieved. PMID: 25588083
Aflibercept for neovascular age-related macular degeneration. PMID: 26857947
Aflibercept (VEGF-TRAP): the next anti-VEGF drug. PMID: 21999177
Aflibercept a new target therapy in cancer treatment: a review. PMID: 26224565
Aflibercept for age-related macular degeneration: a game-changer or quiet addition? PMID: 22813448
Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer. PMID: 34986714
Aflibercept for intravitreal injection: in neovascular age-related macular degeneration. PMID: 23038609
Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats. PMID: 37909622
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial. PMID: 38461843
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. PMID: 30986442
Evaluation of aflibercept in the treatment of metastatic colorectal cancer. PMID: 25152076
A preclinical and clinical review of aflibercept for the management of cancer. PMID: 22264850
Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration. PMID: 23473589
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option. PMID: 27564719
Aflibercept for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis. PMID: 34908485
Aflibercept: newly approved for the treatment of macular edema following central retinal vein occlusion. PMID: 23673531
Ziv-aflibercept: a novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer. PMID: 24128964
Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration. PMID: 26076760
Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept. PMID: 37374329
